EdiTy Therapeutics
Cellular re-programming utilizing the immune system in order to deliver therapeutic proteins directly to the cytoplasm of diseased cells. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€7—11m (Dealroom.co estimates Dec 2023.)
Company register number 516095270
Rehovot Center District (HQ)
Authorizing premium user...